Drug intelligence / Profile preview

BODIPY650-cobalamin

Development stage
Preclinical
Lead developer
University of North Carolina at Chapel Hill
Modality
Small Molecules
Administration
Parenteral
01

Overview

BODIPY650-cobalamin is a light- and X-ray-activated theranostic agent designed for targeted imaging and drug delivery in oncology. It consists of a cobalamin (vitamin B12) scaffold conjugated to the fluorophore BODIPY 650. The compound utilizes the transcobalamin receptor (TCblR/CD320) for cellular uptake, a receptor that is significantly overexpressed in various malignancies, including pancreatic adenocarcinoma (PDAC). The alkylcobalamin linkage is sensitive to both red light (650 nm) and clinical X-ray doses, allowing for the controlled release of cargo. This dual-trigger mechanism enables deep-tissue activation and potential synergy with standard-of-care radiotherapy, facilitating both the visualization of tumors and the localized release of therapeutic agents.

Other names
BODIPY 650-labeled alkylcobalaminBODIPY650-labeled alkylcobalaminBODIPY-650-labeled alkylcobalaminB12-BODIPY650B-12-BODIPY650B 12-BODIPY650
02

Targets

CD320 (Transcobalamin II receptor)

Beyond the preview

Go deeper on BODIPY650-cobalamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BODIPY650-cobalamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call